Frances Rudnick Levin MD

Psychiatry•New York, NY

Addiction

Associate Professor of Psychiatry, Columbia P&S

Join to View Full Profile

1051 Riverside Dr RM 3625New York, NY 10032
Phone+1 212-543-5896
Fax+1 212-543-6018

Education & Training

University of Maryland/Sheppard PrattResidency, Psychiatry, 1989 - 1990
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1985 - 1988
Weill Cornell MedicineClass of 1985

Certifications & Licensure

NY State Medical License 1986 - 2026
NJ State Medical License 2004 - 2025
MD State Medical License 1988 - 1992
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry

Awards, Honors, & Recognition

New York Magazine: Top Doctors Castle Connolly, 2011-2014
Top Doctors: New York Metro Area Castle Connolly, 2007-2014

Clinical Trials

Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1 Start of enrollment: 1998 Feb 01
Completed
Phase 2, Phase 3
HIV Counseling Intervention for Methadone-Maintained Patients - 2 Start of enrollment: 1999 Oct 01
Completed
Phase 1
Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1 Start of enrollment: 2004 Mar 01
Completed
Phase 2
Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2 Start of enrollment: 2003 Mar 01
Completed
Phase 2
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1 Start of enrollment: 1998 Apr 01
Completed
Phase 1
Levetiracetam for the Treatment of Alcohol Dependence and Anxiety Start of enrollment: 2004 Mar 01
Completed
Phase 2
Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder Start of enrollment: 2005 Oct 01
Completed
Phase 2
Dronabinol Treatment for Marijuana Addiction Start of enrollment: 2005 Mar 01
Completed
Phase 2
A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence Start of enrollment: 2007 Feb 01
Completed
Phase 2
Multisite Controlled Trial of Cocaine Vaccine Start of enrollment: 2010 Aug 01
Completed
Phase 2
Combined Pharmacotherapy for Cannabis Dependency Start of enrollment: 2010 Jan 01
Completed
Phase 2, Phase 3
Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence Start of enrollment: 2012 Feb 01
Completed
Phase 1
Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence Start of enrollment: 2013 Jul 01
Completed
Phase 2, Phase 3
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence Start of enrollment: 2014 Jan 01
Completed
Phase 1, Phase 2
Facilitating the Behavioral Treatment of Cannabis Use Disorder Start of enrollment: 2016 Oct 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study.
Chenshu Zhang, Deepika E Slawek, Jonathan Ross, Yuval Zolotov, Felipe Castillo
Cannabis and Cannabinoid Research. 2024-06-01
1 citations
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder.
John J Mariani, Cale Basaraba, Martina Pavlicova, Daniel M Alschuler, Daniel J Brooks
The American Journal of Drug and Alcohol Abuse. 2023-09-03
2 citations
Correction to "Drinking reduction during a clinical trial of cognitive behavioral therapy for alcohol use disorder is associated with reduction in anterior insula-bed ...
A Benjamin Srivastava, Juan Sanchez-Peña, Frances R Levin, John J Mariani, Gaurav H Patel
Alcohol, Clinical & Experimental Research. 2023-07-01

Journal Articles

The Perils of Screening for Unhealthy Drug Use Are a Call to Action for the Mental Health Workforce
Frances Levin, MD, JAMA Psychiatry
American Psychiatric Association Publishing
Adam Bisaga, Frances R Levin, John J Mariani, Maria A Sullivan, Edward V Nunes, National Institutes of Health

Authored Content

The Perils of Screening for Unhealthy Drug Use Are a Call to Action for the Mental Health WorkforceJune 2020

Press Mentions

Effort Underway to Develop First US Guidelines for ADHD in AdultsApril 17th, 2023
AELIS FARMA : Announces a Strategic Collaboration and Option-License Agreement with INDIVIOR for the Treatment of Cannabis-Related DisordersJune 8th, 2021
Do Any Medications Help Ease Marijuana Dependence?March 2nd, 2020
Join now to see all

Grant Support

Substance Abuse Treatment Development And Clinical Research MentoringNational Institute On Drug Abuse2010–2011
Research Fellowship In Substance Abuse DisorderNational Institute On Drug Abuse2008–2011
Multi-Site Controlled Trial Of Cocaine Vaccine (6 Of 6) Columbia University SiteNational Institute On Drug Abuse2008–2011
Extended Release Mixed Amphetamine Salts For Adult ADHD And Cocaine DependenceNational Institute On Drug Abuse2007–2010
Treatment Of Substance Abuse And Psychiatric ComorbidityNational Institute On Drug Abuse2000–2009
Combined Pharmacotherapies For Cocaine DependenceNational Institute On Drug Abuse2006–2008
Agonist Treatment For Marijuana DependenceNational Institute On Drug Abuse2004–2008
Research Fellowship In Substance Abuse DisordersNational Institute On Drug Abuse2004–2007
Marijuana Dependence &Depression: Venlafaxine TreatmentNational Institute On Drug Abuse2003–2006
Marijuana Abusing ADHD Teens: Atomoxetine TreatmentNational Institute On Drug Abuse2004
Novel Pharmacotherapies For Cocaine DependenceNational Institute On Drug Abuse2001–2003
Treatment Of Adult ADHD In Methadone PatientsNational Institute On Drug Abuse1998–2002
Methylphenidate Treatment For Cocaine Abuse And ADHDNational Institute On Drug Abuse1998–2002
Treatment Of Cocaine Abuse And Psychiatric ComorbidityNational Institute On Drug Abuse1995–1998
Treatment Of Cocaine Abuse And Psychiatric ComorbidityNational Institute On Drug Abuse1994